Related references
Note: Only part of the references are listed.Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance
L. J. Brant et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates
Kimberly Page-Shafer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection
L. J. Brant et al.
EPIDEMIOLOGY AND INFECTION (2007)
Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them
K. M. Roy et al.
EPIDEMIOLOGY AND INFECTION (2007)
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia
Lisa Maher et al.
ADDICTION (2006)
Duration of peginterferon therapy in acute hepatitis C: A randomized trial
SM Kamal et al.
HEPATOLOGY (2006)
Peginterferon alfa-2b therapy in acute hepatitis C: Impact of onset of therapy on sustained virologic response
SM Kamal et al.
GASTROENTEROLOGY (2006)
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study
A Judd et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: A cohort study
JK Champion et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Hepatitis C virus infection among injection drug users - Survival analysis of time to seroconversion
H Hagan et al.
EPIDEMIOLOGY (2004)
Failure to diagnose recent hepatitis C virus infections in London injecting drug users
E Aarons et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection
V Sypsa et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Diagnosis of acute hepatitis C: anti-HCV or HCV-RNA?
JM Moller et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients
MP Busch
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2001)